SELLAS Life Sciences Group, Inc. (SLS)
SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S and nelipepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.
Address
7 TIMES SQUARE
NEW YORK, NY 10036
Founded
2006
Number of Employees
16
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)